Perrigo (PRGO) Capital Expenditures Growth (5y) (2018 - 2026)
Perrigo (PRGO) Capital Expenditures Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Perrigo | 1.44 Bn | 1.09 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -21.19% |
| Dec 31, 2025 | -27.77% |
| Sep 27, 2025 | 75.91% |
| Jun 28, 2025 | 84.19% |
| Mar 29, 2025 | -5.48% |
| Dec 31, 2024 | -8.51% |
| Sep 28, 2024 | -5.31% |
| Jun 29, 2024 | -3.31% |
| Mar 30, 2024 | 3.53% |
| Dec 31, 2023 | 56.99% |
| Sep 30, 2023 | 130.88% |
| Jul 1, 2023 | 0.10% |
| Apr 1, 2023 | 11.60% |
| Dec 31, 2022 | 20.85% |
| Oct 1, 2022 | -32.82% |
| Jul 2, 2022 | 13.32% |
| Apr 2, 2022 | -1.60% |
| Dec 31, 2021 | 24.98% |
| Apr 3, 2021 | 5.52% |
| Sep 26, 2020 | -60.04% |